Standard BioTools Inc. Common Stock (LAB) Stock Price

LABStock

$0.64−50.24%52W

Market Cap$252.00M

P/E—

PEG Ratio—

Div yield—

Beta1.41

LAB Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-56.11%

Price vs S&P 500 (4W)-27.44%

VGM Score39.43

Book Value / Share (Quarterly)$1.38

P/TBV (Annual)1.47x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)-4.48%

Cash Flow / Share (Quarterly)$-0.21

Price vs S&P 500 (YTD)-62.67%

Gross Margin (TTM)50.49%

Net Profit Margin (TTM)100.37%

EPS (TTM)$0.22

10-Day Avg Trading Volume1.73M

EPS Excl Extra (TTM)$0.22

Revenue Growth (5Y)-9.18%

EPS (Annual)$-0.20

ROI (Annual)-29.41%

Gross Margin (Annual)49.86%

Net Profit Margin (5Y Avg)-95.42%

Cash / Share (Quarterly)$1.22

P/E Basic Excl Extra (TTM)3.47x

Revenue Growth QoQ (YoY)-7.62%

ROA (Last FY)-22.69%

Revenue Growth TTM (YoY)-45.15%

EBITD / Share (TTM)$-0.23

ROE (5Y Avg)-51.72%

Operating Margin (TTM)-112.85%

Cash Flow / Share (Annual)$-0.40

P/B Ratio0.55x

P/B Ratio (Quarterly)0.60x

Net Income / Employee (Annual)$-194,500

EV / Revenue (TTM)0.29x

Net Interest Coverage (TTM)-15.25x

ROA (TTM)14.31%

EPS Incl Extra (Annual)$-0.20

Current Ratio (Annual)5.70x

Quick Ratio (Quarterly)8.67x

3-Month Avg Trading Volume2.99M

52-Week Price Return-50.24%

P/E Incl Extra (TTM)3.47x

Revenue / Employee (TTM)$219,700

Tangible BV / Share (Quarterly)$1.13

P/S Ratio (Annual)3.45x

Asset Turnover (Annual)0.28x

52-Week High$1.72

Operating Margin (5Y Avg)-86.05%

EPS Excl Extra (Annual)$-0.20

CapEx CAGR (5Y)-8.18%

26-Week Price Return-44.18%

Quick Ratio (Annual)4.94x

13-Week Price Return-43.69%

Total Debt / Equity (Annual)0.00x

Current Ratio (Quarterly)9.10x

Enterprise Value$24.63M

Revenue / Share Growth (5Y)-34.94%

Asset Turnover (TTM)0.14x

Book Value / Share Growth (5Y)29.38%

Revenue / Employee (Annual)$221,600

Inventory Turnover (Annual)1.49x

Pretax Margin (Annual)-113.33%

Cash / Share (Annual)$0.78

3-Month Return Std Dev93.55%

Gross Margin (5Y Avg)42.81%

Net Income / Employee (TTM)$220,500

ROE (Last FY)-29.42%

Net Interest Coverage (Annual)-15.25x

EPS Basic Excl Extra (Annual)$-0.20

Receivables Turnover (TTM)5.57x

Total Debt / Equity (Quarterly)0.00x

EPS Incl Extra (TTM)$0.22

Receivables Turnover (Annual)5.75x

ROI (TTM)17.63%

P/S Ratio (TTM)3.48x

Pretax Margin (5Y Avg)-96.15%

Revenue / Share (Annual)$0.22

Tangible BV / Share (Annual)$1.17

Price vs S&P 500 (52W)-68.80%

P/E Ratio (TTM)3.47x

Year-to-Date Return-49.85%

5-Day Price Return-1.25%

EPS Normalized (Annual)$-0.20

ROA (5Y Avg)-26.47%

Net Profit Margin (Annual)-87.77%

Month-to-Date Return-26.05%

Cash Flow / Share (TTM)$-0.78

EBITD / Share (Annual)$-0.26

Operating Margin (Annual)-129.20%

LT Debt / Equity (Annual)0.02x

ROI (5Y Avg)-38.00%

P/E Excl Extra (TTM)3.47x

LT Debt / Equity (Quarterly)0.00x

EPS Basic Excl Extra (TTM)$0.22

P/TBV (Quarterly)0.96x

P/B Ratio (Annual)1.38x

Inventory Turnover (TTM)2.03x

Pretax Margin (TTM)-107.55%

Book Value / Share (Annual)$1.25

Price vs S&P 500 (13W)-45.65%

Beta1.41x

Revenue / Share (TTM)$0.22

ROE (TTM)17.64%

52-Week Low$0.63

vGradeA

gGradeF

mGradeD

vgmGradeD

LAB Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q2 2026	Aug 5, 2026	-$0.03	-$0.06	-100.00%(-$0.03)
Q1 2026	May 5, 2026	-$0.02	-$0.02	+15.50%(+$0.00)
Q4 2025	Feb 24, 2026	-$0.03	$0.07	+368.80%(+$0.09)
Q3 2025	Nov 4, 2025	-$0.02	-$0.04	-101.50%(-$0.02)
Q2 2025	Aug 11, 2025	-$0.04	-$0.04	+0.25%(+$0.00)

LAB Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

3.86

4.00

Industry Peers — Lab Analytical Instruments(26)

Symbol	Value Score	Growth Score	Momentum Score	Price
LABStandard BioTools Inc. Common Stock	A	F	D	$0.64
AAgilent Technologies Inc.	D	C	B	$153.84
WATWaters Corp	D	C	B	$414.69
ILMNIllumina Inc	D	D	A	$215.59
MTDMettler-Toledo International	D	C	B	$1398.58
RVTYRevvity, Inc.	C	D	A	$128.80
BIOBio-Rad Laboratories, Inc.Class A	C	D	B	$387.70
AVTRAvantor, Inc.	B	F	A	$14.58
BIO.BBio-Rad Laboratories, Inc. Class B	C	D	B	$365.08
BRKRBruker Corporation	D	D	B	$57.08
TXG10x Genomics, Inc. Class A Common Stock	F	D	A	$61.54
ALMRAlamar Biosciences, Inc. Common Stock	—	—	B	$30.71
CTKBCytek Biosciences, Inc. Common Stock	C	C	B	$4.68
MASS908 Devices Inc. Common Stock	C	C	B	$10.73
PACBPacific Biosciences of California, Inc.	D	C	C	$1.40
PREPrenetics Global Limited Class A Ordinary Share	C	D	A	$25.76
EYPTEyePoint, Inc. Common Stock	D	F	F	$4.48
QTRXQuanterix Corporation Common Stock	A	C	D	$2.64
NAUTNautilus Biotechnolgy, Inc. Common Stock	—	—	C	$0.89
SEERSeer, Inc. Class A Common Stock	C	D	C	$1.98
RPIDRapid Micro Biosystems, Inc. Class A Common Stock	C	B	D	$1.57
PRPOPrecipio, Inc. Common Stock	C	A	B	$28.85
HBIOHarvard Bioscience Inc	B	F	A	$7.93
ASTCAstrotech Corporation (DE) Common Stock	C	C	C	$7.15
BNGOBionano Genomics, Inc. Common Stock	A	C	D	$1.17
HLTHTema Healthcare AI ETF	—	F	F	$28.54
PRENWPrenetics Global Limited Warrant	—	—	F	$0.01

About Standard BioTools Inc. Common Stock

Standard BioTools develops and manufactures advanced analytical instruments for biomedical research, primarily using mass cytometry and microfluidics technologies to accelerate drug discovery. The company operates two core segments—Proteomics and Genomics—with Proteomics representing the largest revenue contributor. Its solutions enable researchers to gain deeper insights into health and disease mechanisms, supporting faster therapeutic development. The company generates the majority of its revenue from the Americas.